A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)

Clinical trial NCT01157078 · COMPLETED

Trial details

NCT number: NCT01157078
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder Depression

Start date: 2010-06-01
Primary completion: 2011-11-01
Enrollment: 319

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.